Healthcare News

LYON, France, May 21, 2013 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), a global leader in therapeutic ultrasound, announced that it has entered into definitive agreements with certain institutional...

København, 2013-05-21 15:00 CEST (GLOBE NEWSWIRE) -- Zealand Pharma A/S (NASDAQ OMX København: ZEAL) (“Zealand”) oplyser, at selskabet er inviteret og afholder præsentation på følgende to kommende...

Copenhagen, 2013-05-21 15:00 CEST (GLOBE NEWSWIRE) --   Zealand Pharma A/S (NASDAQ OMX Copenhagen: ZEAL) (“Zealand”), a Danish biotechnology company dedicated to the discovery and development...

- Secondary Analysis by Dr. Rex of sub-set of PillCam COLON trial data shows sensitivity for detecting adenomas that are at least 6 mm and 10 mm to be 88% and 92% respectively and specificity to be...

NEW YORK, May 21, 2013 (GLOBE NEWSWIRE) -- First Independence Corp. (OTCQB:FICF), with its subsidiary, The Codesmart Group, Inc. (collectively, "CodeSmart"), a premier ICD-10 education and solutions...

LEXINGTON, Mass., May 21, 2013 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) announced that a new sub-group analysis from IDA-301, a phase III, randomized, placebo-controlled clinical...

BLAZE study showed once-daily QVA149 significantly improved patient self-reported shortness of breath and lung function compared to placebo and tiotropium 18 mcg[1] SPARK results showed that QVA149...

Stockholm — Medivir AB (OMX: MVIR) meddelar att dess partner Janssen R&D Ireland (Janssen) idag har publicerat primära effekt- och säkerhetsresultat från den globala fas III-studien PROMISE....

Stockholm, Sweden — Medivir AB (OMX: MVIR) reports that its partner Janssen R&D Ireland (Janssen) today announced primary efficacy and safety results from the global phase III PROMISE study. Results...

-- Additional Study Highlights Improved Diagnostic Yield for New 12-Hour PillCam SB -- -- Celebrates Two Millionth PillCam Milestone -- ORLANDO, Fla., May 21, 2013 (GLOBE NEWSWIRE) -- Given...